The global immunodiagnostics market is in the moderate growth stage. The integration of mature clinical chemistry analyzers and restricted specificity and sensitivity of immunoassays have generated demand for integrated immunochemistry analyzers. The increasing volume of tests conducted due to rise in laboratory consolidation has driven the trend of automated analyzers globally.
The increasing adoption of point-of-care testing (POCT) is expected to drive the growth prospects for the global immunodiagnostics market until the end of 2023. Some of the life-threatening conditions that need serious attention include sepsis and acute cardiac infarction. Such serious conditions with high mortality rate drive the necessity for POCT, which, in turn, boosts the demand for immunodiagnostics testing. One of the areas of focus for traditional and non-traditional healthcare companies are POCT for cardiovascular biomarkers. Also, POCT is fast, accurate, portable, and simple to interpret, which helps healthcare providers in alternative healthcare settings. Moreover, the cost of POCT is very low because of its small capillary tubes that need fewer reagents.

Market Analysis and Insights: Global Immunodiagnostics Market
The global Immunodiagnostics market size is projected to reach US$ 17020 million by 2027, from US$ 11100 million in 2020, at a CAGR of 5.8% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Immunodiagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Immunodiagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Immunodiagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Immunodiagnostics market.

Global Immunodiagnostics Scope and Market Size
Immunodiagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Immunodiagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Immunodiagnostic Instruments
Immunoassays

Segment by Application
Oncology and Endocrinology
Hepatitis and Retrovirus Testing
Infectious Disease Testing
GI Stool Testing

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott Laboratories
Danaher
Roche Diagnostics
F.Hoffmann-La Roche
Thermo Fisher Scientific
Johnson＆Johnson
Siemens